Clinical Trial Update: Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating human recombinant interferon gamma-1b for preventing hospital-acquired pneumonia in critically ill patients (PREV-HAP) is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness in Adults
• Hospital-acquired Pneumonia

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: Nantes University Hospital | Conditions: Critically Ill Patients | Phase 2 | Status: UNKNOWN